{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T13:09:43Z","timestamp":1788786583736,"version":"build-2803163510"},"reference-count":45,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:00:00Z","timestamp":1788566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Background: People with chronic neurological disorders may be vulnerable to severe outcomes from vaccine-preventable infections. However, immunization recommendations for these patients may be difficult to identify and apply. This systematic review aimed to identify and describe official guidelines on preventive active immunization for individuals with chronic neurological disorders. Methods: This systematic review was conducted according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 and registered in the PROSPERO International prospective register of systematic reviews (CRD420251005848). Bibliographic databases (PubMed, Embase, Scopus) and grey literature sources were searched to identify official national or international clinical practice guidelines or comparable structured guidance documents providing recommendations relevant to chronic neurological disorders. The search was restricted to countries with a Human Development Index greater than 0.8, to allow comparison across broadly comparable healthcare and socioeconomic contexts. Data were extracted on document characteristics, neurological conditions addressed, vaccines covered, and vaccination-related recommendations. Results: Overall, 12 unique documents were included. Four were vaccination-focused documents including recommendations for neurological disorders, four were disease-management guidelines including vaccination-related recommendations, and four specifically addressed vaccination in selected neurological diseases. Guidance was unevenly distributed across countries, neurological conditions, and document types. Influenza and COVID-19 vaccination were the most consistently addressed vaccines. Multiple sclerosis was the condition with the most detailed guidance, especially regarding vaccination before disease-modifying therapies, live attenuated vaccines, vaccine timing in relation to immunosuppression or relapse, and protection of close contacts. Conclusions: Official immunization guidance for people with chronic neurological disorders remains limited and heterogeneous. Future guidelines should provide clearer and regularly updated recommendations to support vaccination assessment, treatment-sensitive planning, and multidisciplinary coordination.<\/jats:p>","DOI":"10.3390\/vaccines14090777","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T12:12:25Z","timestamp":1788783145000},"page":"777","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Guidelines on Immunization of People with Chronic Neurological Disorders: A Systematic Review"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9472-3263","authenticated-orcid":false,"given":"Giuseppina","family":"Lo Moro","sequence":"first","affiliation":[{"name":"Department of Public Health and Pediatric Sciences, University of Turin, 10126 Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6251-9748","authenticated-orcid":false,"given":"Andreea Mihaela","family":"Butnaru","sequence":"additional","affiliation":[{"name":"Department of Public Health and Pediatric Sciences, University of Turin, 10126 Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9051-777X","authenticated-orcid":false,"given":"Carola","family":"Toffanin","sequence":"additional","affiliation":[{"name":"Department of Public Health and Pediatric Sciences, University of Turin, 10126 Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2206-3069","authenticated-orcid":false,"given":"Anastasia","family":"Cataldo","sequence":"additional","affiliation":[{"name":"Department of Public Health and Pediatric Sciences, University of Turin, 10126 Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9204-0869","authenticated-orcid":false,"given":"Simona","family":"Mazzeo","sequence":"additional","affiliation":[{"name":"Department of Public Health and Pediatric Sciences, University of Turin, 10126 Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4269-6902","authenticated-orcid":false,"given":"Manuela","family":"Martella","sequence":"additional","affiliation":[{"name":"Department of Public Health and Pediatric Sciences, University of Turin, 10126 Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5189-1294","authenticated-orcid":false,"given":"Giacomo","family":"Scaioli","sequence":"additional","affiliation":[{"name":"Department of Public Health and Pediatric Sciences, University of Turin, 10126 Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Bert","sequence":"additional","affiliation":[{"name":"Department of Public Health and Pediatric Sciences, University of Turin, 10126 Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Siliquini","sequence":"additional","affiliation":[{"name":"Department of Public Health and Pediatric Sciences, University of Turin, 10126 Torino, Italy"},{"name":"University Hospital \u201cAzienda Ospedaliero-Universitaria\u201d A.O.U. City of Health and Science of Torino, 10126 Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S1474-4422(19)30411-9","article-title":"The Global Burden of Neurological Disorders: Translating Evidence into Policy","volume":"19","author":"Feigin","year":"2020","journal-title":"Lancet Neurol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/2051013613519217","article-title":"Influenza Vaccination and Treatment in Children with Neurologic Disorders","volume":"2","author":"Havers","year":"2014","journal-title":"Ther. Adv. Vaccines"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41582-022-00646-5","article-title":"Vaccination and Immunotherapies in Neuroimmunological Diseases","volume":"18","author":"Winkelmann","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1212\/CPJ.0000000000001099","article-title":"Uptake and Attitudes About Immunizations in People With Multiple Sclerosis","volume":"11","author":"Marrie","year":"2021","journal-title":"Neurol. Clin. Pract."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.vaccine.2022.11.063","article-title":"Common Issues and Improvement Solution of Vaccine Hesitancy in Children with Underlying Neurological Conditions: Experience from One National Children\u2019s Medical Center in China","volume":"41","author":"Feng","year":"2023","journal-title":"Vaccine"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1007\/s00431-024-05537-z","article-title":"COVID-19 Vaccination Uptake in Children with Epilepsy and Vaccine Hesitancy among Their Parents: A Survey","volume":"183","author":"Lou","year":"2024","journal-title":"Eur. J. Pediatr."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1111\/ene.15368","article-title":"COVID-19 Vaccination Hesitancy among People with Chronic Neurological Disorders: A Position Paper","volume":"29","author":"Rakusa","year":"2022","journal-title":"Eur. J. Neurol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/mus.27224","article-title":"Influenza Vaccination in Autoimmune Neuromuscular Diseases: A Survey of Current Practices and Perceptions","volume":"63","author":"Roy","year":"2021","journal-title":"Muscle Nerve"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"103933","DOI":"10.1016\/j.msard.2022.103933","article-title":"Implementing Education: Personal Communication with a Healthcare Professional Is a Critical Step to Address Vaccine Hesitancy for People with Multiple Sclerosis","volume":"63","author":"Panisset","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/mus.28069","article-title":"Chronic Glucocorticoid Management in Neuromuscular Disease: A Survey of Neuromuscular Neurologists","volume":"70","author":"Stepanian","year":"2024","journal-title":"Muscle Nerve"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Munn, Z., Stern, C., Aromataris, E., Lockwood, C., and Jordan, Z. (2018). What Kind of Systematic Review Should I Conduct? A Proposed Typology and Guidance for Systematic Reviewers in the Medical and Health Sciences. BMC Med. Res. Methodol., 18.","DOI":"10.1186\/s12874-017-0468-4"},{"key":"ref_13","unstructured":"World Health Organization International Classification of Diseases 11th Revision (ICD-11), World Health Organization."},{"key":"ref_14","unstructured":"Institute of Medicine (US) Committee on Standards for Developing Trustworthy Clinical Practice Guidelines (2011). Clinical Practice Guidelines We Can Trust."},{"key":"ref_15","unstructured":"United Nations Development Programme (2024, March 01). Human Development Index (HDI). Available online: https:\/\/hdr.undp.org\/data-center\/human-development-index."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014A Web and Mobile App for Systematic Reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst. Rev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"E839","DOI":"10.1503\/cmaj.090449","article-title":"AGREE II: Advancing Guideline Development, Reporting and Evaluation in Health Care","volume":"182","author":"Brouwers","year":"2010","journal-title":"Can. Med. Assoc. J."},{"key":"ref_18","unstructured":"Australian Technical Advisory Group on Immunisation (2024). Australian Immunisation Handbook."},{"key":"ref_19","unstructured":"Public Health Agency of Canada (2024). Canadian Immunization Guide: Immunization of Persons with Chronic Diseases, Public Health Agency of Canada."},{"key":"ref_20","unstructured":"Health New Zealand\u2014Te Whatu Ora (2024). Immunisation Handbook."},{"key":"ref_21","unstructured":"Society of Infectious Diseases Singapore (2023). Handbook on Adult Vaccination in Singapore, Society of Infectious Diseases Singapore. [4th ed.]."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.neurol.2019.04.001","article-title":"Immunization and Multiple Sclerosis: Recommendations from the French Multiple Sclerosis Society","volume":"175","author":"Lebrun","year":"2019","journal-title":"Rev. Neurol."},{"key":"ref_23","unstructured":"NICE (2019). Cerebral Palsy in Adults."},{"key":"ref_24","unstructured":"NICE (2022). Multiple Sclerosis in Adults: Management."},{"key":"ref_25","unstructured":"Societ\u00e0 Italiana di Neurologia (SIN) (2022). Diagnosi e Terapia della Sclerosi Multipla Nell\u2019adulto, Sistema Nazionale Linee Guida, Istituto Superiore di Sanit\u00e0. Available online: https:\/\/www.iss.it\/documents\/20126\/8331678\/LG-340-SIN_SM.pdf\/b3801eb6-2662-37b6-faeb-3612dd99364c."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1212\/WNL.0000000000008157","article-title":"Practice Guideline Update Summary: Vaccine-Preventable Infections and Immunization in Multiple Sclerosis","volume":"93","author":"Farez","year":"2019","journal-title":"Neurology"},{"key":"ref_27","first-page":"105","article-title":"Recommandations de La Soci\u00e9t\u00e9 Francophone de La Scl\u00e9rose En Plaques \u00ab Vaccinations et Scl\u00e9rose En Plaques \u00bb: Mise \u00e0 Jour 2024","volume":"15","author":"Louapre","year":"2024","journal-title":"Prat. Neurol.-FMC"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1177\/13524585231168043","article-title":"ECTRIMS\/EAN Consensus on Vaccination in People with Multiple Sclerosis: Improving Immunization Strategies in the Era of Highly Active Immunotherapeutic Drugs","volume":"29","author":"Reyes","year":"2023","journal-title":"Mult. Scler. J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.neuarg.2020.09.002","article-title":"Gu\u00edas de Pr\u00e1ctica Para Indicaci\u00f3n y Contraindicaciones de Vacunaci\u00f3n de Pacientes Con Esclerosis M\u00faltiple","volume":"13","author":"Barboza","year":"2021","journal-title":"Neurol. Argent."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.neurol.2021.04.011","article-title":"Infections and Multiple Sclerosis: Recommendations from the French Multiple Sclerosis Society","volume":"177","author":"Papeix","year":"2021","journal-title":"Rev. Neurol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1474-4422(18)30026-7","article-title":"Diagnosis and Management of Duchenne Muscular Dystrophy, Part 3: Primary Care, Emergency Management, Psychosocial Care, and Transitions of Care across the Lifespan","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol."},{"key":"ref_32","unstructured":"UK Health Security Agency Immunisation Against Infectious Disease: The Green Book, Published 11 September 2013 (last update 11 June 2025)."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"E362","DOI":"10.1503\/cmaj.151102","article-title":"Optimizing the Language and Format of Guidelines to Improve Guideline Uptake","volume":"188","author":"Gupta","year":"2016","journal-title":"Can. Med. Assoc. J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"6681","DOI":"10.1016\/j.vaccine.2016.11.015","article-title":"Vaccination of Special Populations: Protecting the Vulnerable","volume":"34","author":"Doherty","year":"2016","journal-title":"Vaccine"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2052544","DOI":"10.1080\/21645515.2022.2052544","article-title":"The Need for Vaccination in Adults with Chronic (Noncommunicable) Diseases in India\u2014Lessons from around the World","volume":"18","author":"Vora","year":"2022","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1007\/s40520-022-02110-2","article-title":"Capturing the Value of Vaccination: Impact of Vaccine-Preventable Disease on Hospitalization","volume":"34","author":"Doherty","year":"2022","journal-title":"Aging Clin. Exp. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1590\/0004-282x-anp-2022-s121","article-title":"Challenges and Insights in Immunization in Patients with Demyelinating Diseases: A Bench-to-Bedside and Evidence-Based Review","volume":"80","author":"Silva","year":"2022","journal-title":"Arq. Neuropsiquiatr."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/eurpub\/ckad134","article-title":"Countering Vaccine Hesitancy: A Systematic Review of Interventions to Strengthen Healthcare Professionals\u2019 Action","volume":"33","author":"Ferrara","year":"2023","journal-title":"Eur. J. Public Health"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e561","DOI":"10.1093\/cid\/ciaf405","article-title":"Multimorbidity Profiles and Severe In-Hospital Outcomes in Adults With Respiratory Syncytial Virus","volume":"82","author":"Ma","year":"2026","journal-title":"Clin. Infect. Dis."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Thaker, J., and Subramanian, A. (2021). Exposure to COVID-19 Vaccine Hesitancy Is as Impactful as Vaccine Misinformation in Inducing a Decline in Vaccination Intentions in New Zealand: Results from Pre-Post Between-Groups Randomized Block Experiment. Front. Commun., 6.","DOI":"10.3389\/fcomm.2021.721982"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"544","DOI":"10.2471\/BLT.21.287654","article-title":"Infodemics and Health Misinformation: A Systematic Review of Reviews","volume":"100","author":"Almeida","year":"2022","journal-title":"Bull. World Health Organ."},{"key":"ref_42","first-page":"e7255","article-title":"Coronavirus Goes Viral: Quantifying the COVID-19 Misinformation Epidemic on Twitter","volume":"12","author":"Kouzy","year":"2020","journal-title":"Cureus"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1016\/j.vaccine.2018.06.044","article-title":"A Report on the Status of Vaccination in Europe","volume":"36","author":"Sheikh","year":"2018","journal-title":"Vaccine"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Di Lorenzo, A., Stefanizzi, P., and Tafuri, S. (2024). Are We Saying It Right? Communication Strategies for Fighting Vaccine Hesitancy. Front. Public Health, 11.","DOI":"10.3389\/fpubh.2023.1323394"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2054602","DOI":"10.1080\/21645515.2022.2054602","article-title":"Burden of Vaccine-Preventable Diseases among at-Risk Adult Populations in the US","volume":"18","author":"Kolobova","year":"2022","journal-title":"Hum. Vaccin. Immunother."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/9\/777\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T12:35:03Z","timestamp":1788784503000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/14\/9\/777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,5]]},"references-count":45,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["vaccines14090777"],"URL":"https:\/\/doi.org\/10.3390\/vaccines14090777","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,5]]}}}